Registration No. 333 -
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER THE
SECURITIES ACT OF 1933
ABBVIE INC.
(Exact
name of registrant as specified in its charter)
Delaware | 32-0375147 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) | |
1 North Waukegan Road
North Chicago, Illinois 60064-6400
(847) 932-7900
(Address of Principal Executive Offices, Including Zip Code)
AbbVie
Savings Program
(Full title of the plan)
Perry C. Siatis, Esq.
Executive Vice President, General Counsel and Secretary
AbbVie Inc.
1 North Waukegan Road
North Chicago, Illinois 60064-6400
(847)
932-7900
(Name, address and telephone number, including area code, of agent for service)
Copies to:
Sophia Hudson, P.C.
Zoey Hitzert
Kirkland & Ellis LLP
601 Lexington Avenue
New York, New York 10022
(212) 446-4800
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | x | Accelerated filer | ¨ | |||
Non-accelerated filer | ¨ | Smaller reporting company | ¨ | |||
Emerging growth company | ¨ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.
EXPLANATORY NOTE
AbbVie Inc. (the “Registrant”) is filing this Registration Statement on Form S-8 (this “Registration Statement”) to register additional shares of common stock of the Registrant, par value $0.01 per share (the “Common Stock”), that may be offered or sold pursuant to the AbbVie Savings Program. This Registration Statement also covers an indeterminate amount of plan interests to be offered or sold pursuant to the AbbVie Savings Program.
This Registration Statement relates to securities of the same class as those registered under a prior Registration Statement and is being filed in accordance with General Instruction E to Form S-8 regarding the registration of additional securities. Pursuant to such instruction, this Registration Statement incorporates by reference the contents of the Registration Statement on Form S-8, File No. 333-185564, filed by the Registrant on December 19, 2012, relating to the AbbVie Savings Program.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 8. Exhibits.
* | Filed herewith. |
Pursuant to the instruction to Item 8 of Form S-8, no opinion of counsel as to the legality of the shares of Common Stock registered with respect to the AbbVie Savings Program is furnished because no original issuance securities are being registered.
The Registrant will submit or has submitted the AbbVie Savings Program and any amendments thereto to the U.S. Internal Revenue Service (the “IRS”) in a timely manner in accordance with the agency’s regulations and has made or will make all changes required by the IRS in order to qualify the program under Section 401 of the U.S. Internal Revenue Code of 1986, as amended.
2
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in North Chicago, Illinois, on November 4, 2024.
AbbVie Inc. | |||
By: | /s/ Scott T. Reents | ||
Name: | Scott T. Reents | ||
Title: | Executive Vice President, Chief Financial Officer |
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below does hereby constitute and appoint Robert A. Michael, Perry C. Siatis, and Scott T. Reents, and each of them, with full power of substitution and full power to act without the others, his or her true and lawful attorney-in-fact and agent to act for him or her in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file this Registration Statement, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in order to effectuate the same as fully, to all intents and purposes, as they or he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, may lawfully do or cause to be done by virtue hereof. Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.
Signature | Title | Date | ||
/s/ Robert A. Michael | Chief Executive Officer and Director (Principal Executive Officer) |
November 4, 2024 | ||
Robert A. Michael | ||||
/s/ Scott T. Reents | Executive Vice President, Chief Financial Officer (Principal Financial Officer) |
November 4, 2024 | ||
Scott T. Reents | ||||
/s/ Kevin K. Buckbee | Senior Vice President, Controller (Principal Accounting Officer) |
November 4, 2024 | ||
Kevin K. Buckbee | ||||
/s/ Richard A. Gonzalez | Executive Chairman of the Board | November 4, 2024 | ||
Richard A. Gonzalez | ||||
/s/ Robert J. Alpern, M.D. | Director | November 4, 2024 | ||
Robert J. Alpern, M.D. | ||||
/s/ Roxanne S. Austin | Director | November 4, 2024 | ||
Roxanne S. Austin |
3
/s/ William H.L. Burnside | Director | November 4, 2024 | ||
William H.L. Burnside | ||||
/s/ Jennifer L. Davis | Director | November 4, 2024 | ||
Jennifer L. Davis | ||||
/s/ Thomas C. Freyman | Director | November 4, 2024 | ||
Thomas C. Freyman | ||||
/s/ Brett J. Hart | Director | November 4, 2024 | ||
Brett J. Hart | ||||
/s/ Melody B. Meyer | Director | November 4, 2024 | ||
Melody B. Meyer | ||||
/s/ Susan E. Quaggin, M.D. | Director | November 4, 2024 | ||
Susan E. Quaggin, M.D. | ||||
/s/ Edward J. Rapp | Director | November 4, 2024 | ||
Edward J. Rapp | ||||
/s/ Rebecca B. Roberts | Director | November 4, 2024 | ||
Rebecca B. Roberts | ||||
/s/ Glenn F. Tilton | Director | November 4, 2024 | ||
Glenn F. Tilton | ||||
/s/ Frederick H. Waddell | Director | November 4, 2024 | ||
Frederick H. Waddell |
4
Pursuant to the requirements of the Securities Act of 1933, the trustees (or other persons who administer the employee benefit plan) have duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in North Chicago, Illinois, on November 4, 2024.
AbbVie Savings Program | |||
By: | /s/ Demetris Crum | ||
Name: | Demetris Crum | ||
Vice President of Total Rewards | |||
Title: | Plan Administrator |
5
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the AbbVie Savings Program of our reports dated February 20, 2024, with respect to the consolidated financial statements of AbbVie Inc. and subsidiaries and the effectiveness of internal control over financial reporting of AbbVie Inc. and subsidiaries included in its Annual Report (Form 10-K) for the year ended December 31, 2023, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP | |
Chicago, IL | |
November 4, 2024 |
Calculation of Filing Fee Tables |
|||
|
|||
|
Table 1: Newly Registered Securities |
---|
Security Type |
Security Class Title |
Fee Calculation Rule |
Amount Registered |
Proposed Maximum Offering Price Per Unit |
Maximum Aggregate Offering Price |
Fee Rate |
Amount of Registration Fee |
|
---|---|---|---|---|---|---|---|---|
1 |
|
|
|
|
$
|
$
|
|
$
|
Total Offering Amounts: |
$
|
$
|
||||||
Total Fee Offsets: |
$
|
|||||||
Net Fee Due: |
$
|
Offering Note |
1 |
|
||||||
|